SCIENTIFIC PROGRAM

* Download program as PDF

MONDAY, AUGUST 25, 2008

08:00  08:30 Opening Ceremony

 

WELCOMING REMARKS
S. Soback, Chairman, Organizing Committee, Israel

 

IMPRESSIONS FROM PAST MEETINGS
P. Lees, UK

 

 

08:30 10:00  Session I

 

PHARMACOKINETICS/PHARMACODYNAMICS
Chairperson: P. Lees, UK

08:30

VETERINARY ANTIMICROBIAL THERAPY – FUTURE and CHALLENGES
S. Soback, Israel

09:00

PLASMA VS. TISSUE CONCENTRATIONS TO PREDICT ANTIBIOTIC  EFFICACY
P-L. Toutain, France

09:30

SHOULD PHYSIOLOGICAL-BASED PHARMACOKINETIC MODELS 
BECOME DE RIGUEUR FOR VETERINARY ANTIMICROBIAL STUDIES?
J. Riviere, USA

10:00

Coffee Break

 

 

10:30 - 12:00

 

PHARMACOKINETICS/PHARMACODYNAMICS
Chairperson: J. Riviere, USA

10:30

STRATEGY TO DESIGN A DOSING SCHEDULE FOR MARBOFLOXACIN BASED ON A STEPWISE PK-PD MODELLING  APPROACH
T. Potter, J.M. Illambas, A. Rycroft, P. Lees, UK

10:45

PHARMACODYNAMICS OF OXYTETRACYCLINE IN VITRO AND EX VIVO AGAINST CALF PATHOGENS
J.M. Illambas, T. Potter, A. Rycroft, P. Lees, UK

 

MONDAY, AUGUST 25, 2008, (continued)

 

 

10:30 – 12:00

 

PHARMACOKINETICS /PHARMACODYNAMICS (continued)

11:00

INFLUENCE OF ADMINISTRATION ROUTE ON THE  BIOTRANSFORMATION OF AMOXICILLIN IN THE PIG
T. Reyns, S. Croubels, S. De Boever, S. Schauvliege, F. Gasthuys, P. De Backer, Belgium

11:15

CEFQUINOME IN GOATS AND SHEEP:  PK/PD INTEGRATION
G.C. Batzias, Greece

11:30

PHARMACOKINETICS AND EFFICACY OF TILMICOSIN IN THE  TREATMENT OF PASTEURELLA HAEMOLITICA  BRONCHOPNEUMONIA IN CALVES
A. Ramadan, Egypt

11:45

Modelling of pharmacokinetic/pharmacodynamic  data to  determine optimum dosage regimen of marbofloxain in  calves: influence of tolfenamic acid concurrent  administration
P.K. Sidhu, P.L. Toutain, F.S. Aliabadi, M.F. Landoni, P. Lees, UK

12:00

Lunch Break

 

 

13:30 – 15.00

 

PHARMACOKINETICS/PHARMACODYNAMICS
Chairperson: P-L Toutain, France

13:30

THE MANY EFFECTS OF PROTEIN BINDING: NONSPECIFIC BINDING  SINKS, TARGETED DELIVERY AND BEYOND
N. Isoherranen, USA

14:00

IMPACT OF BIOLOGIC DIVERSITY ON ANTIMICROBIAL THERAPY IN  VETERINARY MEDICINE
S. Modric, USA

14:30

NANOTHERAPEUTICS: WHAT'S THE "BIG" DEAL WITH "NANO"?
N. Monteiro-Riviere, USA

15:00

Coffee Break

 

 

MONDAY, AUGUST 25, 2008, (continued)

15:30 – 16:30

 

PHARMACOKINETICS/PHARMACODYNAMICS
Chairperson: N. Isoherranen, USA

15:30

Effects of inoculum size on the selection of resistance  in Escherichia coli by marbofloxacin in an in vitro  pharmacodynamic model and in a mouse-thigh infection  model
A. Ferran, A.S. Kesteman, P.L. Toutain, A. Bousquet-Melou, France

15:45

experiences testing cattle farms for presence of bacterial pathogens and possible consequences for the proof of efficacy of antimicrobials  under field conditions
k. Hellman, G. Braun, L. Weissfloch, I. Radeloff, Germany

16:00

PRINCIPLES OF THERAPY (CLINICAL PHARMACOKINETICS  OVERVIEW)
A.M. Amer, Egypt

16:30 – 17.00 Round Table Discussion

BIOEQUIVALENCE ISSUES RELATED TO ANTIMICROBIALS

17.00

Poster Viewing

 

 

TUESDAY, AUGUST 26, 2008

08:30 – 10:00

 

SUSCEPTIBILITY and BREAKPOINTS
Chairperson: M. Martinez, USA

08:30

CLSI STANDARDS AND GUIDELINES: DO THEY REALLY MATTER?
P. Silley, UK

09:00

THE ROLE OF PK/PD IN THE ESTABLISHMENT OF SUSCEPTIBILITY BREAKPOINTS: A CLSI PERSPECTIVE
M. Martinez, USA

09:30

THE CLINICAL RELEVANCE OF SUSCEPTIBILITY BREAKPOINTS
J. Watts, USA

10.00

BREAK POINT DISCUSSION

10:30

Coffee Break

 

 

11:00 – 12:00 Session 6 Congress Hall 1

10:30

SUSCEPTIBILITY and BREAKPOINTS
Chairperson: S. Brown, USA

11:00

COMPARISON OF ANTIMICROBIAL RESISTANCE IN ESCHERICHIA  COLI FROM HEALTHY CATTLE OF DIFFERENT AGES FROM ORGANIC  AND CONVENTIONAL DAIRY FARMS.
U. Grönlund Andersson, K. Ekström, S. Thyselius, B. Bengtsson,  Sweden

11:15

AN ASSESSMENT OF THE RELATIONSHIP BETWEEN USAGE AND RESISTANCE USING MONITORING DATA
C. Chauvin, E. Jouy, M. Bruneau, A. Perrin-Guyomard, M. Querrec,
P. Sanders, France

11:30

RELATEDNESS OF AMPICILLIN RESISTANT ESCHERICHIA COLI  STRAINS ISOLATED FROM PIGS DURING AMPICILLIN TREATMENT
D. Bibbal, V. Dupouy, M.F. Prere, P.L. Toutain, A. Bousquet-Melou, France

11:45

ACSSuT MULTI-DRUG RESISTANCE AMONG SALMONELLA ISOLATES  OF ANIMAL ORIGIN
P.J. Fedorka-Cray, J. Frye, J. Haro, USA

12:00

Lunch Break

 

 

TUESDAY, AUGUST 26, 2008 (continued)

13:30 – 15:00

 

ANTIBIOTICS and RESISTANCE
Chairperson: J. Watts, USA

13:30

BIOFILMS IN VETERINARY MEDICINE: FACTS AND HYPOTHESES
J. Fink-Gremmels, The Netherlands

14:00

Tulathromycin pharmacodynamics: When MIC’s don’t tell the whole story
S. Brown, USA

14:30

COMPARISON OF ANTIMICROBIAL RESISTANCE IN OLD AND RECENT  STAPHYLOCOCCUS AUREUS ISOLATES FROM BROILERS
M. Nemati, K. Hermans, U.  Lipinska, O. Denis, A. Deplano, M. Struelens,
L. A. Devriese, F. Pasmans, F. Haesebrouck, Belgium

14:45

EVALUATION OF THE POTENTIAL INTERACTIONS BETWEEN ANTIMICROBIALS AND BIOCIDES ON THE PREVALENCE OF ANTIMICROBIAL RESISTANCE
J. Fink-Gremmels, The Netherlands

15:00

Coffee Break

 

 

TUESDAY, AUGUST 26, 2008 (continued)

15:30 – 16:30   Session 8  Congress Hall 1

 

 ANTIBIOTICS and RESISTANCE
Chairperson: J. Fink-Gremmels

15:30

Molecular analysis of trimethoprim resistance in Escherichia coli isolates collected in the BfT-GermVet  monitoring study
K. Kadlec, S. Schwarz, Germany

15:45

Influence of inoculum size on the selection of marbofloxacin resistant mutants in experimental rat Klebsiella pneumoniae lung infection
A.S. Kesteman, A. Ferran, A. Perrin-Guyomard, M. Laurentie,
P.L. Toutain, A. Bousquet-Mélou, France

16:00

ANTIMICROBIAL SUSCEPTIBILITY OF CLOSTRIDIUM SPIROFORME
F. Agnoletti, T.Ferro , A. Guolo, M. Cocchi , C. Bacchin, B.Marcon, L.Bano,
I. Drigo, Italy

16:15

DETECTION OF EXTENDED- SPECTRUM β-LACTAMASES AMONG  PATHOGENS ISOLATED FROM CHICKENS IN CHINA AND THEIR  ANTIBIOTIC RESISTANCE
L. Yuan, G-Z. Hu, J-H. Liu, Z-M. Liu, J. Mo, Y-S. Pan, China

16:30

Poster Viewing

20:00

Gala Dinner

 

 

WEDNESDAY, AUGUST 27, 2008

08:30 – 10:00

 

ANTIBIOTICS and HUMAN SAFETY
Chairperson: L. Ritter, Canada

08:30

ANTIMICROBIAL RESISTANCE IN THE FOOD CHAIN: EPIDEMIOLOGY AND CONTROL OPTIONS
F.M. Aarestrup, Denmark

09:00

REDUCING CO- AND CROSS-RESISTANCE, AN ACHIEVABLE  PARADIGM OR FOOLS PARADISE?"
P. Silley, UK

09:30

HUMAN FOOD SAFETY CONSIDERATIONS AND CHALLENGES FOR  ANTIMICROBIAL NEW ANIMAL DRUGS
S. Steve Yan, A.H. Fernandez, J.M. Gilbert, USA

10:00

Coffee Break

 

 

10:30 – 12:00

 

ANTIBIOTICS and HUMAN SAFETY
Chairperson: P. Silley, UK

10:30

SALES OF VETERINARY ANTIMICROBIALS IN SWITZERLAND, 2006
C. Müntener, F. Stucki, F.R. Althaus, B. Gassner, Switzerland

10:50

PATTERNS OF ANTIMOCROBIAL USE IN DOGS AND CATS IN  DENMARK, NORWAY AND SWEDEN
V.F. Jensen, C. Greko, K. Grave, M. Norström, M. Bangen, L. Petterson,   O.E. Heuer, Denmark

11:10

DETERMINATION OF CHLORAMPHENICOL RESIDUES IN ROYAL JELLY WITH LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY: VALIDATION OF THE METHOD BASED ON 2002/657/EC
S. Menotta, V. Carone, E. Bolognesi, E. Caprai, G. Fedrizzi, Italy

11:30

EVALUATION OF TETRACYCLINE POSITIVE SLAUGHTER ANIMALS WITH THE NOUWS ANTIBIOTIC TEST: REJECTION OF SLAUGHTER ANIMALS WITHOUT CONFIRMATORY ANALYSIS?
M.G. Pikkemaat, M.L.B.A. Rapallini, J.G. vander A, The Netherlands

12:00

Lunch Break

 

 

WEDNESDAY, AUGUST 27, 2008 (continued)

13:30 – 15:00

ANTIBIOTICS and ANALYTICAL PROCEDURES
Chairperson: J. Hajslova

13:30

DEVELOPMENT OF A MULTI VETERINARY DRUG RESIDUE TESTING METHOD USING A TRIPLE QUAD LINEAR ION TRAP LC/MS/MS HYBRID SYSTEM
K. Albin and M. Svoboda, Germany

14:00

ANALYSIS DEPENDENT PHARMACOKINETICS ; LC/MS/MS VERSUS OTHER TECHNIQUES
M. Britzi and S. Soback, Israel

14:30

Approaches to screening of antibiotic residues in bovine tissues
K. Mastovska, M.J. Schneider, S.J. Lehotay, A.R. Lightfield, USA

15:00

Coffee Break

15:30

ANTIBIOTICS and RESIDUES
Chairperson: S. Soback

15:30

LONG DEPLETION TIME OF TETRACYCLINE IN CHICKENS FOR  FATTENING
F. Gamboa, F.H. Suarez, V. Caballero, M.A. Martínez, I. Ares,
M. Martínez, M.R. Martínez-Larrañaga, Spain

15:45

DEVELOPMENT OF A NEW HPLC METHOD FOR THE DETERMINATION  OF CLAZURIL (APPERTEX®) IN EGGS AND PLASMA FROM LAYING  HENS AFTER SINGLE AND MULTIPLE TREATMENT
M. Giorgi, G. Soldani, Italy

16:00

PROPOSALS FOR WITHDRAWAL TIME OF SHEEP MILK FOR SOME COMMONLY USED ANTIMICROBIAL DRUGS
L.V. Athanasiou, D.C. Orfanou, I.A. Fragkou, D.A. Gougoulis, C. Nerou, 
V.L. Katsoudas, G.C. Vachratidis, G.C. Fthenakis, Greece

16:30

Poster Viewing